Smith Anglin Financial »

Cognition Therapeutics shares owned by Smith Anglin Financial

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Smith Anglin Financial from 13F filings

Historical chart of Smith Anglin Financial investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Smith Anglin Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Smith Anglin Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $22k 12k 1.82
2023-12-31 $22k 12k 1.85

More positions owned by Smith Anglin Financial

Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core S&p500 Etf (IVV)
John Hancock Exchange Traded Multifactor Mi (JHMM)
Cambria Etf Tr Shshld Yield Etf (SYLD)
Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Ishares Tr S&p 500 Val Etf (IVE)
American Centy Etf Tr Us Eqt Etf (AVUS)
Cambria Etf Tr Emrg Sharehldr (EYLD)
Ishares Tr Core Div Grwth (DGRO)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Vanguard Specialized Funds Div App Etf (VIG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)

View all positions for Smith Anglin Financial

Top funds holding Cognition Therapeutics

Pathstone Holdings
AIGH Capital Management
Vanguard Group
Worth Venture Partners
Kestra Advisory Services
American Financial Group
Mercer Global Advisors
Commonwealth Equity Services
Texas Capital Bank Wealth Management Services
Fca Corp
Castle Wealth Management
HighTower Advisors
Sigma Planning
Northeast Financial Consultants
Bangor Savings Bank

View all funds holding Cognition Therapeutics